United Kingdom· GB-APID-40031511000001103
Bimzelx 160mg/1ml solution for injection pre-filled pens
A bimekizumab product containing bimekizumab, registered in United Kingdom by UCB Pharma Ltd. The same ATC class is registered in 14 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Bimekizumab is registered in 14 of 19 countries.
Countries holding a registration under ATC L04AC21 (bimekizumab), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Bimekizumab · ATC L04AC21
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of bimekizumab costs, country by country.
Normalised to the WHO defined daily dose (5.7 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Bimekizumab · price per daily dose (5.7 mg)
USD · FX 28 Sept 2026
- CH Switzerland$43.14
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Bimekizumab
- Manufacturer
- UCB Pharma Ltd
- Country
- United Kingdom (GB)
- ATC code
- L04AC21
- ATC class
- Bimekizumab
- Defined daily dose
- 5.7 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin05413787220328
- gtin05413787220236
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bimekizumab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBIMZELXUCB Pharma SA, Brusel
- IcelandBimzelxUCB Pharma S.A.*
- NorwayBimzelxUCB Pharma S.A. (2)
- PolandBimzelxUCB Pharma S.A.
- BelgiumBimzelx 160 mgUCB Pharma
- SwedenBimzelx 160 mg Injektionsvätska, lösning i förfylld injektionspennaUCB Pharma S.A.
- SpainBIMZELX 160 MG SOLUCION INYECTABLE EN JERINGA PRECARGADAUcb Pharma
- SwitzerlandBimzelx
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Bimzelx
- Liechtenstein · Bimzelx
- Norway · Bimzelx
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a5d5dd74-8a04-4f34-8bd8-d033ae66b29d GET /v1/drugs/a5d5dd74-8a04-4f34-8bd8-d033ae66b29d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "40031511000001103",
"desc": "Bimzelx 160mg/1ml solution for injection pre-filled pens (UCB Pharma Ltd)",
"form": "Solution for injection",
"vpid": "40038811000001106",
"source": "dmd",
"vtm_id": "1340106001",
"strength": "160 mg",
"substance": "Bimekizumab",
"ingredient": "Bimekizumab",
"supplier_code": "2089701000001105"
}See everything about bimekizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.